John Dobak
2021
In 2021, John Dobak earned a total compensation of $3.4M as President and Chief Executive Officer at DermTech, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $203,000 |
|---|---|
| Option Awards | $1,300,174 |
| Salary | $580,000 |
| Stock Awards | $1,298,591 |
| Other | $413 |
| Total | $3,382,178 |
Dobak received $1.3M in option awards, accounting for 38% of the total pay in 2021.
Dobak also received $203K in non-equity incentive plan, $580K in salary, $1.3M in stock awards and $413 in other compensation.
Rankings
In 2021, John Dobak's compensation ranked 3,956th out of 12,406 executives tracked by ExecPay. In other words, Dobak earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,956 out of 12,406 | 68th |
Division Services | 959 out of 2,290 | 58th |
Major group Health Services | 114 out of 252 | 55th |
Industry group Medical And Dental Laboratories | 28 out of 73 | 62nd |
Industry Medical Laboratories | 28 out of 73 | 62nd |
Source: SEC filing on April 11, 2023.
Dobak's colleagues
We found four more compensation records of executives who worked with John Dobak at DermTech in 2021.